Compare GFL & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GFL | RVTY |
|---|---|---|
| Founded | 2007 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 11.8B |
| IPO Year | 2019 | 1994 |
| Metric | GFL | RVTY |
|---|---|---|
| Price | $43.44 | $89.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $56.60 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | 0.14% | ★ 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $7.27 | $6.34 |
| Revenue Next Year | $7.12 | $5.10 |
| P/E Ratio | ★ $5.95 | $43.24 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.83 | $81.36 |
| 52 Week High | $52.00 | $118.30 |
| Indicator | GFL | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 33.00 |
| Support Level | $42.34 | $88.42 |
| Resistance Level | $43.90 | $94.75 |
| Average True Range (ATR) | 1.00 | 3.01 |
| MACD | -0.01 | -0.61 |
| Stochastic Oscillator | 40.64 | 3.71 |
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.